Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization
Authors
Keywords
-
Journal
ACADEMIC RADIOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-02-27
DOI
10.1016/j.acra.2021.01.024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis
- (2020) Jungang Hu et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin in Hepatocellular Cancer with Extrahepatic Spread
- (2019) Ning Lyu et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial
- (2019) Eric Assenat et al. BRITISH JOURNAL OF CANCER
- Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
- (2019) MinKe He et al. JAMA Oncology
- Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
- (2019) Mi Young Jeon et al. PLoS One
- Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial
- (2019) Masaaki Kondo et al. BMC CANCER
- Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib
- (2019) Atsushi Hiraoka et al. Liver Cancer
- Potential Areas of Interest in a Trial of Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin for Hepatocellular Carcinoma
- (2019) Lola-Jade Palmieri et al. JAMA Oncology
- Comparison of hepatic arterial infusion chemotherapy between 5-FU based continuous infusion chemotherapy and CDDP monotherapy for advanced hepatocellular carcinoma
- (2018) Tomokazu Kawaoka et al. HEPATOLOGY RESEARCH
- Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma
- (2018) Ning Lyu et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization
- (2017) Sangheun Lee et al. Hepatology International
- Role of Albumin in Growth Inhibition in Hepatocellular Carcinoma
- (2017) Ezgi Bağırsakçı et al. ONCOLOGY
- Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease
- (2017) Martha M Kirstein et al. United European Gastroenterology Journal
- Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
- (2016) Kenji Ikeda et al. JOURNAL OF GASTROENTEROLOGY
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- (2015) Joong-Won Park et al. LIVER INTERNATIONAL
- Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis
- (2015) Y. Zhang et al. ONCOLOGIST
- A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
- (2014) Do Seon Song et al. JOURNAL OF GASTROENTEROLOGY
- Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization
- (2014) Sadahisa Ogasawara et al. ONCOLOGY
- Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan
- (2013) K Nouso et al. BRITISH JOURNAL OF CANCER
- A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis
- (2013) Masafumi Ikeda et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
- (2013) Wolfgang Sieghart et al. HEPATOLOGY
- Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
- (2013) Shukui Qin et al. JOURNAL OF CLINICAL ONCOLOGY
- Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib
- (2012) Matthias Pinter et al. RADIOLOGY
- Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma
- (2012) HIROKI NISHIKAWA et al. Experimental and Therapeutic Medicine
- Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
- (2011) M. Pinter et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- 5-fluorouracil arterial infusion + interferon therapy for highly advanced hepatocellular carcinoma: A multicenter, randomized, phase II study
- (2011) Morito Monden et al. HEPATOLOGY RESEARCH
- Hepatic Arterial Infusion Chemotherapy Using Low-Dose 5-Fluorouracil and Cisplatin for Advanced Hepatocellular Carcinoma
- (2010) Kazuomi Ueshima et al. ONCOLOGY
- Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth
- (2009) Zheng Wang et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma
- (2008) Masaharu Yoshikawa et al. HEPATOLOGY RESEARCH
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started